3-year outcomes for anti-NMDAR encephalitis, skin biopsies for diagnosis of human prion diseases, the career benefits of graduate degrees in public health and/or business administration

5/12/2024

Neurology Today in 5

0:00

5:02

In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on a study highlighting three-year outcomes for patients with anti-NMDAR encephalitis, an analysis comparing the diagnostic efficacy of skin biopsies vs. CSF tests for human prion diseases, and the ways in which a graduate degree in public health and/or business administration can shape career pathways for neurologists.

Otros episodios de "Neurology Today in 5"

Middle meningeal artery embolization and subdural hematoma, processed red meat and dementia risk, and editor picks for best neurology advances of 2024.
16/1/2025
4:24
In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the safety of middle meningeal artery embolization for chronic subdural hematoma, the processed red meat and risk for dementia, and editors’ picks for the best advances of 2024.
Magnesium sulfate for cerebral palsy, novel gene therapy for muscular dystrophies, chronic traumatic encephalitis and suicidality in retired NFL players.
2/1/2025
4:59
In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the latest Cochrane review of magnesium sulfate to prevent cerebral palsy; a novel mRNA system for gene therapy for muscular dystrophies, and the perception of CTE and suicidality risk in retired NFL players.
No te pierdas ningún episodio de “Neurology Today in 5”. Síguelo en la aplicación gratuita de GetPodcast.
Revised criteria for diagnosing MS, AI for alleviating administrative burden, neonatal neurocritical care as a growing subspecialty
19/12/2024
5:20
In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on proposed updated criteria for diagnosing MS before symptoms manifest, the use of large language models to address administrative burden with electronic medical records, and the growth of training programs in neonatal neurocritical care.
3-year outcomes for anti-NMDAR encephalitis, skin biopsies for diagnosis of human prion diseases, the career benefits of graduate degrees in public health and/or business administration
5/12/2024
5:02
In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on a study highlighting three-year outcomes for patients with anti-NMDAR encephalitis, an analysis comparing the diagnostic efficacy of skin biopsies vs. CSF tests for human prion diseases, and the ways in which a graduate degree in public health and/or business administration can shape career pathways for neurologists.
Cardiovascular effects of antiseizure therapies, social determinants of health on children with MS, coverage for blood-based biomarkers for Alzheimer’s
21/11/2024
4:40
In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the higher risk for cardiovascular effects with certain antiseizure therapies on adults with epilepsy, the impact of social determinants of health on children with MS, and the status of coverage for blood-based tests for Alzheimer’s disease.
Fever prevention and stroke, environmental toxins and Parkinson’s, cholesterol overload and ALS progression
7/11/2024
4:20
In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on fever prevention and stroke outcomes, the impact of air pollution and other environmental toxins on Parkinson’s, and the role of cholesterol overload in ALS progression and disease risk.
Blood test for ALS, new migraine target reduces headache days, latest data on eculizumab for neuromyelitis optica spectrum disorder
17/10/2024
4:41
In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the potential of a new blood biomarker for ALS, a PACP-targeted migraine therapy, and a real-world review of data on eculizumab for neuromyelitis optica spectrum disorder. This Podcast is being Sponsored by LocumTenens.com
Eastern equine encephalitis, systems for anti-amyloid therapies, new protocol for eye stroke
3/10/2024
4:32
In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on Eastern equine encephalitis relief, systems developed to meet demand for anti-amyloid therapies, and a new protocol for timely diagnosis and treatment for eye stroke in the emergency department. This Podcast is being Sponsored by LocumTenens.com
Brain circuit underlying placebo pain relief, common Parkinson’s gene variants, blood biomarker testing for Alzheimer’s
19/9/2024
4:46
In this week’s podcast, Neurology Today’s editor-in-chief highlights new findings on brain pathways in placebo pain relief, that Parkinson’s gene variants are more common than thought, and why there is momentum behind new blood biomarker tests for Alzheimer’s.
Alzheimer’s diagnosis criteria, AI and Parkinson’s severity, neurotoxicity of racism
5/9/2024
5:04
In this week’s podcast, Neurology Today’s editor-in-chief highlights a new workgroup’s recommendations on biomarkers for diagnosing Alzheimer’s, AI’s ability to track Parkinson’s severity from brief videos, and the latest research on how racism leads to neural changes and accelerated aging.

Más episodios

Descubre los mejores podcast en la aplicación gratuita de GetPodcast.

Suscríbete a tus podcast favoritos, escucha episodios cuando estés sin conexión y déjate sorprender por las recomendaciones personalizadas.

Politica de privacidad
Aviso legal
España

3-year outcomes for anti-NMDAR encephalitis, skin biopsies for diagnosis of human prion diseases, the career benefits of graduate degrees in public health and/or business administration

Neurology Today in 5

Otros episodios de "Neurology Today in 5"

Middle meningeal artery embolization and subdural hematoma, processed red meat and dementia risk, and editor picks for best neurology advances of 2024.

Magnesium sulfate for cerebral palsy, novel gene therapy for muscular dystrophies, chronic traumatic encephalitis and suicidality in retired NFL players.

Revised criteria for diagnosing MS, AI for alleviating administrative burden, neonatal neurocritical care as a growing subspecialty

3-year outcomes for anti-NMDAR encephalitis, skin biopsies for diagnosis of human prion diseases, the career benefits of graduate degrees in public health and/or business administration

Cardiovascular effects of antiseizure therapies, social determinants of health on children with MS, coverage for blood-based biomarkers for Alzheimer’s

Fever prevention and stroke, environmental toxins and Parkinson’s, cholesterol overload and ALS progression

Blood test for ALS, new migraine target reduces headache days, latest data on eculizumab for neuromyelitis optica spectrum disorder

Eastern equine encephalitis, systems for anti-amyloid therapies, new protocol for eye stroke

Brain circuit underlying placebo pain relief, common Parkinson’s gene variants, blood biomarker testing for Alzheimer’s

Alzheimer’s diagnosis criteria, AI and Parkinson’s severity, neurotoxicity of racism